Search results
Sanders: Diabetes and weight loss drugs could bankrupt U.S. health care system
The Burlington Free Press· 11 hours agoThe diabetes drug Ozempic and the weight-loss drug Wegovy could bankrupt America's health care...
Cartman Gets Introduced to Ozempic in First Trailer for South Park: The End of Obesity: Watch
Consequence of Sound via Yahoo News· 2 days agoThe latest South Park special for Paramount+ will take aim at weight-loss drugs and the American...
‘South Park: The End Of Obesity’ Sets Paramount+ Premiere Date – Watch The Teaser
Deadline Hollywood· 2 days ago'South Park' special event 'The End of Obesity' has locked in a premiere date on Paramount+.
Buy a dip in Novo Nordisk stock on Wegovy strength: analysts By Investing.com
Investing.com· 4 days agoAnalysts at Bank of America are bullish on Novo Nordisk (NYSE:NVO) stock, stating they would be...
Medicare could save $500 million with coverage change
Newsweek· 2 days agoAnti-obesity medications are a hot topic in the medical world, and many Americans remain conflicted...
What Is Normal Weight Obesity—and Why Can’t Ozempic Help?
Slate· 4 days agoIn 2020 more than 40 percent of Americans reported experiencing weight stigma, not only from friends...
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Motley Fool via Yahoo Finance· 7 days agoToday, the dividend is only about half of earnings, so there is a long runway for dividend growth,...
Paramount+ Announces ‘South Park: The End of Obesity’
Animation World Network· 2 days agoThe advent of new weight loss drugs has a huge impact on everyone in South Park in the “new event”...
Through tradition and trade, tribe in rural Kansas works to reclaim its food sovereignty - The...
The Morning Sun· 5 days agoFor those who live on the Iowa Tribe of Kansas and Nebraska's reservation in the rural northeast...
Wegovy will 'bankrupt the health care system,' says Sen. Sanders in new report
BenefitsPRO· 1 day agoSanders, an independent senator from Vermont, has ratcheted up criticism of Novo over what he's...